Skip to main content

Table 5 Effect of EGML or GCE on plasma lipids and atherogenic biomarkers in overweight subjects

From: Does Glycine max leaves or Garcinia Cambogiapromote weight-loss or lower plasma cholesterol in overweight individuals: a randomized control trial

Groups Placebo GCE EGML
  Before After Before After Before After
HTR (%) 21.36 ± 1.56 22.49 ± 1.94 21.08 ± 1.48 23.14 ± 1.38 20.43 ± 1.17 23.77* ± 1.16
AI 4.51 ± 0.58 4.31 ± 0.49 4.68 ± 0.33 3.82 ± 0.31 4.14 ± 0.35 3.43 ± 0.21
FFA (mmol/L) 0.54 ± 0.04 0.50 ± 0.03 0.49 ± 0.03 0.41 ± 0.03 0.49 ± 0.03 0.40* ± 0.02
PL (mmol/L) 1.58 ± 0.05 1.53 ± 0.05 1.61 ± 0.05 1.56 ± 0.05 1.64 ± 0.06 1.56 ± 0.04
Apo A-1 ( μg/dL) 1.82 ± 0.10 1.56 ± 0.04 1.72 ± 0.08 1.85 ± 0.12 1.66 ± 0.03 1.88 ± 0.15
Apo B ( μg/dL) 4.11 ± 0.33 4.10 ± 0.34 6.27 ± 0.63 5.55 ± 0.50 5.17 ± 0.40 4.70 ± 0.37
Apo B/Apo A-1 2.26 ± 0.63 2.62 ± 0.63 3.65 ± 0.42 3.00 ± 0.29 3.11 ± 0.23 2.50* ± 0.26
  1. Values are mean ± S.E.; *p < 0.05, **< 0.01, ***p < 0.001 indicate significant difference before and after 10 weeks by Students' t-test; GCE, Garcinia cambogia extract; EGML, Extract of Glycine max leaves; HTR, [HDL-C/Total-C)×100]; AI, atherogenic Index, ([(Total-C)]-[HDL-C]/[HDL-C]); FFA, free fatty; PL, phospholipid; Apo A-1, Apolipoprotein A-1; Apo B, Apolipoprotein B.